Peptide Reference
Ipamorelin + CJC-1295 Stack
Ipamorelin and CJC-1295 Combination
The most popular growth hormone peptide stack combining a GHRP (Ipamorelin) with a GHRH (CJC-1295) for synergistic GH release.
Status
research
Category
growth hormone
Typical cost
$150-300/month combined
Mechanism
Ipamorelin stimulates ghrelin receptors triggering GH pulses. CJC-1295 amplifies GHRH signaling. Together they produce greater GH elevation than either alone through synergistic mechanisms.
Potential benefits
- Synergistic GH elevation
- Better than either alone
- Fat loss
- Muscle preservation
- Improved recovery
- Better sleep
Reported side effects
- Water retention
- Numbness/tingling
- Increased hunger
- Injection site reactions
Common dosing references
subcutaneous
Ipamorelin 100-300mcg + CJC-1295 100-300mcg · Daily or 5x weekly
12-16 weeks
Research notes
GHRP + GHRH synergy
1990
Combined use produces greater GH elevation than single agents
Regulatory and sourcing notes
Research chemicals only. Not FDA-approved. Popular in anti-aging and fitness communities.
Research peptides. Most popular GH stack. Requires two separate injections or combined preparation.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.
Related peptides